Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight off, but ...

Eli Lilly will pay up to $1.3bn for Superluminal Medicines to discover and progress small-molecule therapeutics for G protein ...

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

体重の減少率は、ウォール街の期待レンジの下限にとどまった。リリーの経口肥満治療薬「オルフォルグリプロン（orforglipron）」は、ノボノルディスクの注射薬「ウゴービ」と同等の効果があることを投資家は期待していた。ウゴービの臨床試験では、被験者の ...

To make things a little less confusing, we’re here with all the info you need about popular weight loss med Mounjaro.

Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its debut in Africa ...

Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.

Trump administration demands lower prices in the U.S., forcing the pharmaceutical company to raise them in other markets ...

FOR years, Emma Morris hid from cameras, avoided mirrors and felt like a prisoner in her own body because of her weight. But ...

One study found a modest risk of developing non-arteritic anterior ischaemic optic neuropathy (NAOIN), a rare eye condition ...

Eli Lilly shares fell after the company’s oral drug showed less weight loss than hoped. It could still be huge.

Eli Lilly has hiked the price of popular weight loss injections. The pharmaceutical giant, which manufactures the active ...